The Experience of the Derivo® Embolisation Device in Intracranial Aneurysms

Ourresults indicated a safe aneurysm occlusion with optimum morbidity and mortality values despite the fact that almost one-third ofthe patients presented with subarachnoid haemorrhage.KEYWORDS: Derivo® embolisation device, Cerebrovasc

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:AIM: To investigate the safety and efficacy of Derivo® embolisation device (DED), a new-generation flow diverter designed to treatcerebrovascular aneurysms, and its long-term clinical outcomes.MATERIAL and METHODS: In total, 146 patients with 182 aneurysms were treated with DED.

📊

Temel Bulgular & Veri:The mean age of the participantswas 51.5 years; among them, 46 (31.5%) presented with acute subarachnoid haemorrhage.

💡

Sonuç & Katkı:Ourresults indicated a safe aneurysm occlusion with optimum morbidity and mortality values despite the fact that almost one-third ofthe patients presented with subarachnoid haemorrhage.KEYWORDS: Derivo® embolisation device, Cerebrovasc

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

AIM: To investigate the safety and efficacy of Derivo® embolisation device (DED), a new-generation flow diverter designed to treatcerebrovascular aneurysms, and its long-term clinical outcomes.MATERIAL and METHODS: In total, 146 patients with 182 aneurysms were treated with DED. The mean age of the participantswas 51.5 years; among them, 46 (31.5%) presented with acute subarachnoid haemorrhage. The mean aneurysm size was 8.3 mm,and 12 aneurysms were involved the vertebrobasilar system. Ophthalmic aneurysms account for most internal carotid artery (ICA)aneurysms.RESULTS: The Glasgow Coma Scale (GCS) score of 12 patients was <15. DED was associated with a mortality rate of 2.7% andpermanent morbidity rate of 3.4%, and a complete aneurysm occlusion rate was achieved in 78.7% of cases after 7.02 months.CONCLUSION: The DED device is a new-generation flow diverter with excellent opening behaviour and navigational benefits. Ourresults indicated a safe aneurysm occlusion with optimum morbidity and mortality values despite the fact that almost one-third ofthe patients presented with subarachnoid haemorrhage.KEYWORDS: Derivo® embolisation device, Cerebrovasc

🔖

Bu Makaleye Atıf Yap

DAĞLIOĞLU, E., AKMANGİT, İ., AÇIK, V., ALAGÖZ, F., SAYIN, B., UCKUN, O. M., BELEN, A. D., ARAT, A. (2020). The Experience of the Derivo® Embolisation Device in Intracranial Aneurysms. Turkish Neurosurgery, Cilt: 30 - Sayı: 1, 30–37. https://ajindex.com/articles/404295

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

Akgul E, Onan HB, Akpinar S, Balli HT, Aksungur EH: The DERIVO embolization device in the treatment of intracranial aneurysms: Short- and midterm results. World Neurosurgery 95:229-240, 2016 2. Cagnazzo F, di Carlo DT, Cappucci M, Lefevre PH, Costalat V, Perrini P: Acutely ruptured intracranial aneurysms treated with flow-diverter stents: A systematic review and meta-analysis. AJNR Am J Neuroradiol 39(9):1669-1675, 2018 3. Cognard C: Commentary on ‘Curative cerebrovascular reconstruction with the Pipeline embolization device: The emergence of definitive endovascular therapy for intracranial aneurysms. J Neurointerventional Surgery 10 Suppl 1:i8, 2018 4. Colby GP, Bender MT, Lin LM, Beaty N, Caplan JM, Jiang B, Westbroek EM, Varjavand B, Campos JK, Huang J, Tamargo RJ, Coon AL: Declining complication rates with flow diversion of anterior circulation aneurysms after introduction of the pipeline flex: Analysis of a single-institution series of 568 cases. J Neurosurgery 12:1-7, 2018 5. Fischer S, Aguilar-Pérez M, Henkes E, Kurre W, Ganslandt O, Bäzner H, Henkes H: Initial Experience with p64: A novel mechanically detachable flow diverter for the treatment of intracranial saccular sidewall aneurysms. Am J Neuroradiol 36:2082-2089, 2015 6. Foa Torres G, Roca F, Noguera A, Godes J, Petrocelli S, Aznar I, Ales S, Muszynski P, Maehara R, Vicente M, Pumar JM: Silk flow-diverter stent for the treatment of complex intracranial aneurysms: A one-year follow-up multicenter study. Interv Neuroradiol 24:357-362, 2018 7. Goertz L, Dorn F, Kraus B, Borggrefe J, Schlamann M, Forbrig R, Turowski B, Kabbasch C: Safety and efficacy of the derivo embolization device for the treatment of ruptured intracranial aneurysms. J Neurointerv Surg 11(3):290-295, 2019 8. Gurkas E, Kaya T, Daglioglu E, Akmangit I, Belen D, Peker A, Dede D, Arat A: Silk device for the treatment of intracranial aneurysms. Part 1: Peri-procedural results, technical aspects and learning curve. Turkish Neurosurgery 26:525-532, 2016 9. Kallmes DF, Brinjikji W, Cekirge S, Fiorella D, Hanel RA, Jabbour P, Lopes D, Lylyk P, McDougall CG, Siddiqui A: Safety and efficacy of the pipeline embolization device for treatment of intracranial aneurysms: A pooled analysis of 3 large studies. J Neurosurgery 127:775-780, 2017 10. Kaya T, Daglioglu E, Gurkas E, Akmangit I, Peker A, Belen D, Dede D, Elhan AH, Arat A: Silk device for the treatment of intracranial aneurysms, part 2: Factors related to clinical and angiographic ou